Camp4 Therapeutics (CAMP) Capital Expenditures (2023 - 2026)

Camp4 Therapeutics has reported Capital Expenditures for 3 years, with the latest figure at $279000.0 in Q2 2025.

• Quarterly Capital Expenditures rose 933.33% year-over-year to $279000.0 in Q2 2025, while the trailing twelve-month figure through Mar 2026 was $279000.0 (down 3.79% YoY) and the FY2025 annual result came in at $279000.0, down 36.73% from the prior year.
• Capital Expenditures advanced to $279000.0 in Q2 2025 per CAMP's latest filing, from $263000.0 in the prior quarter.
• Over five years, Capital Expenditures peaked at $622000.0 in Q4 2023 and troughed at $27000.0 in Q2 2024.
• A 3-year average of $268400.0 and a median of $263000.0 in 2024 frame the typical range for Capital Expenditures.
• The sharpest annual moves came in 2024 and 2025: Capital Expenditures slumped 57.72% in 2024, then soared 933.33% in 2025.
• Over 3 years, Capital Expenditures stood at $622000.0 in 2023, then plunged by 57.72% to $263000.0 in 2024, then climbed by 6.08% to $279000.0 in 2025.
• According to Business Quant data, Capital Expenditures over the past three periods registered $279000.0, $263000.0, and $27000.0 for Q2 2025, Q4 2024, and Q2 2024 respectively.